Moderna遭FDA拒收信函针对mRNA流感疫苗,强烈反驳监管机构理由。
Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
生物技术与制药领域的最新动态
Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
Moderna accuses FDA of shifting standard as agency refuses flu shot review
Chutes & Ladders—Moderna CMO steps down in leadership mix-up
Moderna's latest CMO steps down after barely a year
Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years
Moderna cancer vaccine holds up; IO Biotech considers a sale
#JPM26: Moderna CEO Bancel talks deals, flu and RSV strategy
Moderna, searching for a rebound, to seek approval of mRNA flu shot
Moderna seeks flu vaccine approvals; Neumora Alzheimer's data
Moderna gets funding for H5 pandemic influenza vaccine
After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3
Moderna's reshaping rolls on with 3 more pipeline purges
Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna
Moderna secures $1.5B lifeline as it looks to break even in 2028